Moderna Begins Testing Booster Shot Aimed at Omicron
The new study will focus on a single omicron-specific booster dose in about 600 adults.
COVID19 Vaccine
COVID-19 Vaccination During Chemotherapy Deemed Safe for Gastrointestinal Cancers
The study revealed no new safety signals compared with previous reports.
A New Year for COVID-19 and the Pandemic: Triumphs and Challenges
Experts review COVID-19-related triumphs of 2021 and challenges for 2022.
NCCN Endorses Full COVID-19 Vaccination for Cancer Patients
The NCCN Advisory Committee offers guidance on the timing of COVID-19 vaccination in cancer patients.
Severe COVID-19 Outcomes Rare After Primary Vaccination
Severe COVID-19 outcomes were observed in 1.5 per 10,000 vaccinated people.
Pfizer Says Omicron-Specific Vaccine Ready by March
Both Pfizer and Moderna are developing omicron-specific COVID-19 vaccines.
BNT162b2 Still Effective, but Less So, Against Omicron
The effectiveness of 2 doses of the Pfizer-BioNTech COVID-19 vaccine was reduced during an omicron variant proxy period in South Africa.
Serious Adverse Effects From COVID-19 Vaccines Reported Rarely
Full vaccination dose, younger age, female sex, and previously having had COVID-19 were associated with greater odds of adverse effects.
FDA Shortens Time to Booster After Moderna Vaccine to Five Months
A similar time window for boosters is already in place for people who received the Pfizer/BioNTech vaccine.
BNT162b2 Vaccine Effectiveness 92 Percent for Teens Ages 12 to 17
The delta variant was the predominant SARS-CoV-2 strain at the time of the study.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...